Commonwealth Equity Services LLC Has $25.41 Million Stock Position in The Clorox Company (NYSE:CLX)

Commonwealth Equity Services LLC boosted its stake in shares of The Clorox Company (NYSE:CLX) by 0.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 156,473 shares of the company’s stock after purchasing an additional 315 shares during the quarter. Commonwealth Equity Services LLC owned 0.13% of Clorox worth $25,413,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the stock. Oppenheimer & Co. Inc. grew its position in Clorox by 1.6% during the third quarter. Oppenheimer & Co. Inc. now owns 17,310 shares of the company’s stock worth $2,820,000 after buying an additional 268 shares in the last quarter. OneDigital Investment Advisors LLC acquired a new stake in shares of Clorox during the 3rd quarter worth approximately $207,000. CIBC Asset Management Inc increased its position in shares of Clorox by 6.7% during the third quarter. CIBC Asset Management Inc now owns 21,144 shares of the company’s stock valued at $3,445,000 after purchasing an additional 1,332 shares during the period. Empirical Finance LLC raised its stake in shares of Clorox by 2.2% in the third quarter. Empirical Finance LLC now owns 4,274 shares of the company’s stock valued at $696,000 after purchasing an additional 93 shares in the last quarter. Finally, Natixis Advisors LLC lifted its position in Clorox by 8.3% in the third quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock worth $10,341,000 after purchasing an additional 4,839 shares during the period. 78.53% of the stock is owned by institutional investors.

Clorox Stock Performance

Shares of Clorox stock opened at $147.32 on Monday. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The firm has a 50 day simple moving average of $154.20 and a 200 day simple moving average of $160.23. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The firm has a market cap of $18.15 billion, a P/E ratio of 40.25, a P/E/G ratio of 2.62 and a beta of 0.45.

Clorox (NYSE:CLX) last released its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the company posted $2.16 earnings per share. Sell-side analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.31%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox’s dividend payout ratio (DPR) is presently 133.33%.

Wall Street Analysts Forecast Growth

CLX has been the topic of several analyst reports. Wells Fargo & Company boosted their price target on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price target on shares of Clorox in a research report on Thursday, January 30th. Barclays lifted their price objective on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a report on Wednesday, February 5th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, JPMorgan Chase & Co. boosted their price target on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $159.62.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.